Journal of Heterocyclic Chemistry · 1968 · 18 citations · 16 references
Natural SciencesChemistryMedicinal ChemistryOrganic ChemistryOrganometallic ChemistrySynthetic Medicinal ChemistryHeterocycle SynthesisHeterocyclic ChemistryPyridazine ChemistryPyrimidine Chemistry
Abstract The synthesis of 5‐chloro‐8‐(ω‐dialkylaminoalkylamino)pyrazino[2,3‐ d ]pyridazine (II) proceeded smoothly when 5,8‐dichloropyrazino[2,3‐ d ]pyridazine (I) was allowed to react with ω‐dialkylaminoalkylamines. Similarly, the reaction of 5,8‐dichloropyrido[2,3‐ d ]pyridazine (IV) with ω‐dialkylaminoalkylamines gave the two expected products 8‐chloro‐5‐(ω‐dialkylaminoalkylamino)pyrido[2,3‐ d ]pyridazine (V) and 5‐chloro‐8‐(ω‐dialkylaminoalkylamino)pyrido[2,3‐ d ]pyridazine (VI) in a 2:3 ratio. 4,7‐Dichloroimidazo[4,5‐ d ]pyridazine (XII) was found to be much less reactive towards nucleophilic substitutions and more vigorous conditions resulted in disubstituted products (XIII). 7‐Chloroimidazo[4,5‐ c ]pyridazine (XVIII) was also found to be much less reactive towards nucleophilic substitution. In both of these cases one of the imidazole nitrogen atoms was blocked by a tetrahydropyranyl group which increased the reactivities and led to the desired monosubstituted products XVII from XII and in the latter case the expected products (XIX).
16
Roland K. Robins, Erik F. Godefroi, Edward C. Taylor et al. · Journal of the American Chemical Society · 1961 · 103 citations